Unsu Jung

Array ( [id] => 6343034 [patent_doc_number] => 20100330028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'COMBINATION THERAPY FOR CHRONIC DERMAL ULCERS' [patent_app_type] => utility [patent_app_number] => 12/595051 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18759 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330028.pdf [firstpage_image] =>[orig_patent_app_number] => 12595051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546589 [patent_doc_number] => 20090156466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Characterization of a MEKK binding site and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/078808 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8347 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 105 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156466.pdf [firstpage_image] =>[orig_patent_app_number] => 12078808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949875 [patent_doc_number] => 20080306001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'TRANSCRIPTIONAL MODULATION OF EXTRACELLULAR MATRIX (ECM) OF DERMAL FIBROBLASTS' [patent_app_type] => utility [patent_app_number] => 12/062155 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9764 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306001.pdf [firstpage_image] =>[orig_patent_app_number] => 12062155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290925 [patent_doc_number] => 20090023655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Biased Ligands for Receptors Such as the PTH Receptor' [patent_app_type] => utility [patent_app_number] => 12/060600 [patent_app_country] => US [patent_app_date] => 2008-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 32598 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023655.pdf [firstpage_image] =>[orig_patent_app_number] => 12060600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808118 [patent_doc_number] => 20080171696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Pharmacodynamically enhanced therapeutic proteins' [patent_app_type] => utility [patent_app_number] => 12/077036 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14400 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171696.pdf [firstpage_image] =>[orig_patent_app_number] => 12077036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11190535 [patent_doc_number] => 09421331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-23 [patent_title] => 'Combination pressure therapy' [patent_app_type] => utility [patent_app_number] => 13/202543 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34489 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479205 [patent_doc_number] => 20100092469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'ANTAGONISTS OF A NON-SELECTIVE CATION CHANNEL IN NEURAL CELLS' [patent_app_type] => utility [patent_app_number] => 12/522802 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 70503 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092469.pdf [firstpage_image] =>[orig_patent_app_number] => 12522802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846269 [patent_doc_number] => 08455450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof' [patent_app_type] => utility [patent_app_number] => 12/520699 [patent_app_country] => US [patent_app_date] => 2007-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 52 [patent_no_of_words] => 24462 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391613 [patent_doc_number] => 20100303777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'DELIVERY OF BINDING MOLECULES TO INDUCE IMMUNOMODULATION' [patent_app_type] => utility [patent_app_number] => 12/518843 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12068 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303777.pdf [firstpage_image] =>[orig_patent_app_number] => 12518843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916195 [patent_doc_number] => 20080096796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Peptides That Stimulate Cell Survival and Axon Regeneration' [patent_app_type] => utility [patent_app_number] => 11/950065 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11158 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096796.pdf [firstpage_image] =>[orig_patent_app_number] => 11950065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6371315 [patent_doc_number] => 20100075343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'NOVEL PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/524036 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 21564 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075343.pdf [firstpage_image] =>[orig_patent_app_number] => 12524036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6456121 [patent_doc_number] => 20100105758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'USE OF AN ADENOSINE ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/312410 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7876 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105758.pdf [firstpage_image] =>[orig_patent_app_number] => 12312410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727943 [patent_doc_number] => 20080207487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'MANUFACTURING PROCESS FOR THE PRODUCTION OF POLYPEPTIDES EXPRESSED IN INSECT CELL-LINES' [patent_app_type] => utility [patent_app_number] => 11/934700 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 35539 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207487.pdf [firstpage_image] =>[orig_patent_app_number] => 11934700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4521000 [patent_doc_number] => 07951371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling' [patent_app_type] => utility [patent_app_number] => 11/982415 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 17947 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951371.pdf [firstpage_image] =>[orig_patent_app_number] => 11982415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574990 [patent_doc_number] => 20090142351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof' [patent_app_type] => utility [patent_app_number] => 11/978832 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8059 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142351.pdf [firstpage_image] =>[orig_patent_app_number] => 11978832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882768 [patent_doc_number] => 08969532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography' [patent_app_type] => utility [patent_app_number] => 11/866969 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 38802 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11866969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6371547 [patent_doc_number] => 20100075375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'METHODS FOR THE PURIFICATION OF POLYPEPTIDE CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/444380 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 38836 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075375.pdf [firstpage_image] =>[orig_patent_app_number] => 12444380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440539 [patent_doc_number] => 20100104501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'PRSS23 AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET' [patent_app_type] => utility [patent_app_number] => 12/445494 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37794 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104501.pdf [firstpage_image] =>[orig_patent_app_number] => 12445494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251576 [patent_doc_number] => 20100028264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'LTBP2 AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET' [patent_app_type] => utility [patent_app_number] => 12/444596 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 38029 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028264.pdf [firstpage_image] =>[orig_patent_app_number] => 12444596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374480 [patent_doc_number] => 20100081136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'CRTAC AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET' [patent_app_type] => utility [patent_app_number] => 12/444227 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 38311 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081136.pdf [firstpage_image] =>[orig_patent_app_number] => 12444227 [rel_patent_id] =>[rel_patent_doc_number] =>)